311 related articles for article (PubMed ID: 30137027)
1. The innate immune receptor TREM-1 promotes liver injury and fibrosis.
Nguyen-Lefebvre AT; Ajith A; Portik-Dobos V; Horuzsko DD; Arbab AS; Dzutsev A; Sadek R; Trinchieri G; Horuzsko A
J Clin Invest; 2018 Nov; 128(11):4870-4883. PubMed ID: 30137027
[TBL] [Abstract][Full Text] [Related]
2. Modulation of Liver Inflammation and Fibrosis by Interleukin-37.
Mountford S; Effenberger M; Noll-Puchta H; Griessmair L; Ringleb A; Haas S; Denk G; Reiter FP; Mayr D; Dinarello CA; Tilg H; Bufler P
Front Immunol; 2021; 12():603649. PubMed ID: 33746950
[No Abstract] [Full Text] [Related]
3. Trem-2 Promotes Emergence of Restorative Macrophages and Endothelial Cells During Recovery From Hepatic Tissue Damage.
Coelho I; Duarte N; Barros A; Macedo MP; Penha-Gonçalves C
Front Immunol; 2020; 11():616044. PubMed ID: 33628208
[TBL] [Abstract][Full Text] [Related]
4. Intravital imaging of splenic classical monocytes modifying the hepatic CX3CR1
Han C; Zhai Y; Wang Y; Peng X; Zhang X; Dai B; Leng Y; Zhang Z; Qi S
Theranostics; 2024; 14(5):2210-2231. PubMed ID: 38505603
[TBL] [Abstract][Full Text] [Related]
5. Eosinophil expression of Triggering receptor expressed on myeloid cells-1 (TREM-1) restricts type 2 lung inflammation.
Bowen JL; Keck K; Baruah S; Nguyen KH; Thurman AL; Pezzulo AA; Klesney-Tait J
J Leukoc Biol; 2024 Mar; ():. PubMed ID: 38547428
[TBL] [Abstract][Full Text] [Related]
6. Met-CCL5 modifies monocyte subpopulations during liver fibrosis regression.
Stock MK; Hammerich L; do O NT; Berres ML; Alsamman M; Heinrichs D; Nellen A; Trautwein C; Tacke F; Wasmuth HE; Sahin H
Int J Clin Exp Pathol; 2013; 6(4):678-85. PubMed ID: 23573314
[TBL] [Abstract][Full Text] [Related]
7. Clodronate-nintedanib-loaded exosome-liposome hybridization enhances the liver fibrosis therapy by inhibiting Kupffer cell activity.
Ji K; Fan M; Huang D; Sun L; Li B; Xu R; Zhang J; Shao X; Chen Y
Biomater Sci; 2022 Feb; 10(3):702-713. PubMed ID: 34927632
[TBL] [Abstract][Full Text] [Related]
8. TREM1: Activation, signaling, cancer and therapy.
Li C; Cai C; Xu D; Chen X; Song J
Pharmacol Res; 2024 Jun; 204():107212. PubMed ID: 38749377
[TBL] [Abstract][Full Text] [Related]
9. CCR2+TREM-1+ monocytes promote natural killer T cell dysfunction contributing towards HBV disease progression.
Wu X; Zhao W; Miao Q; Shi S; Wei B; Luo L; Cai B
Immunol Res; 2024 May; ():. PubMed ID: 38814567
[TBL] [Abstract][Full Text] [Related]
10. Recruitment of large peritoneal macrophages to capsular fibrosis developed on the liver surface.
Balog S; Jeong S; Asahina K
FASEB J; 2024 Jan; 38(1):e23327. PubMed ID: 38019178
[TBL] [Abstract][Full Text] [Related]
11. Role of triggering receptor expressed on myeloid cells-1 in kidney diseases: A biomarker and potential therapeutic target.
Fan Y; Xu Y; Huo Z; Zhang H; Peng L; Jiang X; Thomson AW; Dai H
Chin Med J (Engl); 2024 May; ():. PubMed ID: 38809056
[TBL] [Abstract][Full Text] [Related]
12. Macrophages marc(o) the difference in liver inflammation?
Zwicker C; Scott CL
Trends Immunol; 2024 Jun; 45(6):400-402. PubMed ID: 38789321
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Surgical Brain Injury by Immune Tolerance Induced by Peripheral Intravenous Injection of Biotargeting Nanoparticles Loaded With Brain Antigens.
Tian Z; Xu L; Chen Q; Feng R; Lu H; Tan H; Kang J; Wang Y; Yan H
Front Immunol; 2019; 10():743. PubMed ID: 31024567
[TBL] [Abstract][Full Text] [Related]
14. Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies.
Ju C; Tacke F
Cell Mol Immunol; 2016 May; 13(3):316-27. PubMed ID: 26908374
[TBL] [Abstract][Full Text] [Related]
15. Gossypetin targets the liver-brain axis to alleviate pre-existing liver fibrosis and hippocampal neuroinflammation in mice.
Xu C; Tai H; Chu Y; Liu Y; He J; Wang Y; Su B; Li S
Front Pharmacol; 2024; 15():1385330. PubMed ID: 38860164
[TBL] [Abstract][Full Text] [Related]
16. TREM1 is the new kid on the block for the aging-associated innate immune response and Alzheimer's disease.
Heneka MT
Nat Immunol; 2024 Jun; 25(6):938-940. PubMed ID: 38831103
[No Abstract] [Full Text] [Related]
17. Inflammatory processes in the liver: divergent roles in homeostasis and pathology.
Ahmed O; Robinson MW; O'Farrelly C
Cell Mol Immunol; 2021 Jun; 18(6):1375-1386. PubMed ID: 33864004
[TBL] [Abstract][Full Text] [Related]
18. The characteristics and pivotal roles of triggering receptor expressed on myeloid cells-1 in autoimmune diseases.
Gao S; Yi Y; Xia G; Yu C; Ye C; Tu F; Shen L; Wang W; Hua C
Autoimmun Rev; 2019 Jan; 18(1):25-35. PubMed ID: 30408584
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of monoacylglycerol lipase, an anti-inflammatory and antifibrogenic strategy in the liver.
Habib A; Chokr D; Wan J; Hegde P; Mabire M; Siebert M; Ribeiro-Parenti L; Le Gall M; Lettéron P; Pilard N; Mansouri A; Brouillet A; Tardelli M; Weiss E; Le Faouder P; Guillou H; Cravatt BF; Moreau R; Trauner M; Lotersztajn S
Gut; 2019 Mar; 68(3):522-532. PubMed ID: 30301768
[TBL] [Abstract][Full Text] [Related]
20. STING-mediated inflammation in Kupffer cells contributes to progression of nonalcoholic steatohepatitis.
Yu Y; Liu Y; An W; Song J; Zhang Y; Zhao X
J Clin Invest; 2019 Feb; 129(2):546-555. PubMed ID: 30561388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
